ArticleThoracic cancer2022

Association of thyroid transcription factor-1 with the efficacy of immune-checkpoint inhibitors in patients with advanced lung adenocarcinoma.

Kenji Nakahama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.